Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
POINT: Use of Pharmacogenetics in Guiding Treatment with Warfarin
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical pharmacogenomics and osteoporosis.ORCID iD: 0000-0002-6368-2622
2009 (English)In: Clinical Chemistry, ISSN 0009-9147, E-ISSN 1530-8561, Vol. 55, no 4, p. 709-711Article in journal, Editorial material (Refereed) Published
Place, publisher, year, edition, pages
2009. Vol. 55, no 4, p. 709-711
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-98491DOI: 10.1373/clinchem.2008.115964PubMedID: 19181736OAI: oai:DiVA.org:uu-98491DiVA, id: diva2:174695
Available from: 2009-02-24 Created: 2009-02-24 Last updated: 2017-12-13

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Wadelius, Mia

Search in DiVA

By author/editor
Wadelius, Mia
By organisation
Clinical pharmacogenomics and osteoporosis
In the same journal
Clinical Chemistry
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 495 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf